The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants

Table 2

Postnatal comprehensive metabolic panel (CMP) characteristics of 221 extremely premature infants by BPD status.

	Control ()	BPD ()		value
Total protein (g/L)	42.9 (39.2, 45.7)	41.2 (37.6, 43.8)	-2.083	0.037
Albumin (ALB, g/L)	24.8 (22.7, 27.1)	24.1 (21.8, 26.2)	-1.730	0.084
Alanine aminotransferase (ALT, U/L)	7.0 (6.0, 8.0)	6.0 (5.0, 8.0)	-1.266	0.205
Aspartate aminotransferase (AST, U/L)	25.0 (19.0, 32.0)	25.5 (19.8, 34.0)	-0.770	0.441
Alkaline phosphatase (ALP, U/L)	310.0 (212.5, 398.2)	215.5 (173.5, 330.7)	-3.074	0.002
Blood urea nitrogen (BUN, mmol/L)	7.5 (4.7, 10.7)	10.2 (7.5, 13.0)	-4.335
Total calcium (Tca, mmol/L)	2.3 (2.2, 2.5)	2.3 (2.2, 2.5)	-0.374	0.709
Sodium (Na, mmol/L)	134.7 (131.3, 138.1)	134.2 (129.8, 137.6)	-1.378	0.168
Potassium (K, mmol/L)	4.6 (4.2, 4.9)	4.7 (4.3, 5.28)	-1.825	0.068
Magnesium (Mg, mmol/L)	0.8 (0.7, 0.9)	0.9 (0.8, 1.0)	-3.208	0.001
Creatine kinase-MB (CK-MB, U/L)	10.0 (7.0, 13.7)	10.0 (6.0, 15.0)	-0.559	0.576

Data were displayed as median (interquartile range). The CMP test was performed between postnatal days 5 and 8.